The Nobel-winning scientists opened new doors in our understanding of the structure of proteins and came up with ways to ...

Two Chinese biotechs are testing CRISPR gene editing in boys with muscular dystrophy, even as projects at U.S. companies like ...

Opinion: An upcoming FDA ad comm on a treatment for the ultra rare Barth syndrome can’t use the normal measuring sticks for ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

A trade group representing compounding pharmacies sued the FDA for a “reckless and arbitrary” decision to remove Eli Lilly's ...

Scholar Rock yesterday reported that its experimental treatment for spinal muscular atrophy succeeded in a Phase 3 trial, ...

The billionaire co-founder of Mark Cuban Cost Plus Drugs said Tuesday that Harris "likes the idea of transparency, and she ...

Scientific American editor-in-chief Laura Helmuth and opinion editor Megha Satyanarayana join "First Opinion Podcast" to discuss the magazine endorsing Kamala Harris.

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

On “The View,” Kamala Harris announced a plan to fund home care under Medicare by cutting into the pharmaceutical industry’s ...

Today's health news includes the winner of the Nobel Prize in physics, Hurricane Helene causing IV fluid shortages, and HIV ...